ABSTRACT An epidemic of symptoms suggestive of occupational asthma in workers in a mineral analysis laboratory necessitating exposure to vapours of hydrochloric, hydrofluoric, nitric, perchloric, and sulphuric acid solutions was investigated. Variable airflow obstruction was confirmed by serial measurement of FEV, in two subjects who showed 18% and 22% fall in FEV, during a workshift. Of a workforce of 21 laboratory staff, 20 took part in a study of ventilatory capacity and bronchial reactivity. All but one subject had normal ventilatory capacity but five had bronchial hyperreactivity (PC20 < 8 mg/ml histamine). Four of the five with hyperreactivity had a history of chest tightness at work whereas only two subjects with chest tightness had PC20 > 8 mg/ml (p < 0-01). Other work related symptoms were cough (two subjects) and breathlessness (three subjects). Four of the subjects with bronchial hyperreactivity were atopic, suggesting that hyperreactivity may have predated exposure to irritant material at work and resulted in their being susceptible to the development of symptoms and raises the possibility of identifying susceptible subjects by preplacement examination. In two of these subjects, however, bronchial reactivity has returned to normal after 205 and 376 days away from work, suggesting that bronchial inflammation resulted from occupational exposure to acid vapours.
Seven workers in a laboratory which employed up to 21 technical and clerical staff to analyse mineral samples for the mining industry developed chest tightness and retrosternal discomfort, breathlessness or cough, or both, which started during the summer months at a time when the workload of the laboratory increased greatly. All related their symptoms to their work.
Rock samples from throughout Australia and elsewhere are received by the laboratory for analysis of their mineral content. They are crushed finely in a shed that houses crushing machinery and then transferred to a laboratory building where they are weighed in a weighing room and transferred to another room where quantitative analysis is undertaken. The minerals are dissolved in concentrated solutions of hydrochloric, hydrofluoric, nitric, perchloric, and sulphuric acids including "aqua regia", after which they are "digested" by heating them in open beakers in fume cupboards for [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] hours. The resulting solutions are then submitted for atomic absorption (AA) and inductive coupled plasma (ICP) spectrometry in separate adjacent rooms in the laboratory building.
Opportunities for exposure to vapours from concenAccepted 6 April 1987 trated acid solutions occurred in decanting the acids and transferring the beakers to and from the fume cupboards, from escape of vapours beneath the sashes of the fume cupboards during digestion, and from recirculation of the air exhausted from the fume cupboards into the laboratory building's air conditioning system at times when the wind blew exhausted air from the discharge vent over the roof of the building towards the intake vent.
This study was undertaken to investigate the prevalence of symptoms in the laboratory workforce, the relation of these symptoms to opportunities for exposure to acid vapours, and the occurrence of changes in lung function accompanying the symptoms. It was designed as a cross sectional survey to include all current employees and those who had' recently resigned and also those absent from work because of respiratory symptoms. Four current employees also agreed to make serial measurements of FEV, during a day at work to determine if objective changes in lung function were associated with symptoms at work. Additionally, three of the subjects whose bronchial reactivity was found to be increased had serial measurements of reactivity while they continued at work and after they had left work.
By the time the study was conducted the volume of 381 Nine subjects (eight of whom were laboratory workers) thought that work had affected their chests (table  1) . These included all subjects with work related cough, dyspnoea, or chest tightness and four ofthe five subjects with PC20 < 8 mg/mi. The fifth subject with PC20 < 8 mg/ml was the subject with chronic airflow obstruction (subject 9) who attributed his chest condition to cigarettes. All the subjects who complained of dyspnoea or chest tightness at work had worked in the laboratory area (main laboratory or atomic absorption room). The one subject who had work related symptoms and worked outside the main laboratory in the rock crushing shed complained only of cough. Ten subjects were atopic including the man with chronic airflow obstruction and four of the five subjects with PC20 < 8 mg/ml. The association between atopy and bronchial reactivity, however, was not statistically significant in this small group. Nor was there an association between bronchial reactivity and rhinitis. Six subjects in the study gave symptoms of "chronic bronchitis" including the oldest, the 58 year old male smoker with known chronic airflow obstruction (subject 9) and two of the crushing plant workers, one a current smoker and the other an ex-smoker. The presence of chronic bronchitis was not significantly associated with smoking status or work related symptoms in this small group. All participants apart from subject 9 had FEV, greater than 83% of the predicted level (mean 106%, SD 12%).
Five subjects gave a history of hay fever and all were atopic. There was, however, no significant statistical association between the presence ofcurrent rhinitis on the one hand and atopy or other respiratory symptoms on the other. In particular there was no relationship of current rhinitis with work related lower respiratory symptoms.
Two subjects, one of whom worked in the rock crushing area, considered that activity at work resulted in cough. Three complained of breathlessness at work and six thought that work was associated with chest tightness. All subjects who complained of breathlessness or chest tightness worked in the main laboratory and four of them had PC20 < 8 mg/ml (p < 0-01).
Serology for respiratory viruses (adenovirus, influenza A and B, parainfluenza 1, 2, and 3, respiratory syncitial virus, Q fever, coronavirus, psittacosis, Lymphogranuloma venereum, Mycoplasma pneumoniae) was performed in all subjects with respiratory symptoms. No evidence of recent infection was found.
WORKSHIFT CHANGES IN FEV, Serial measurements of FEV, starting from the time they arrived at work were made in subjects 9, 11, 12, and 13 (figure) who remained in employment at the laboratory. Three of these (subjects I1, 12, and 13) had complained of work related breathlessness or chest tightness or both, and subject 9 was a cigarette smoker with chronic bronchitis and chronic airflow obstruction who used a salbutamol metered dose inhaler at irregular intervals for the relief of breathlessness. A 22% fall was recorded in subject 1 I while she was using the atomic absorption spectrometer and was associated with the sensation of retrosternal discomfort and chest tightness. Subject 12 12 and 10 had regained normal reactivity. Reactivity in subject 11 was unchanged after 15 months from last exposure, although she had no chest tightness, breathlessness, wheeze, or cough when seen in November 1986. other observations of an association between bronchial reactivity and atopic status,'3 although this association was not statistically significant in this small group and there was no association of bronchial reactivity with rhinitis. The implication of this finding would be that preplacement testing of subjects for the presence of hyperreactive airways may identify those who are susceptible to exposure.
The alternative explanation for the findings of this study is that bronchial hyperreactivity in these subjects resulted from repeated exposure to irritant acid fumes which caused bronchial inflammation and hyperreactivity.7 ' A precedent for this is found with exposure of man or animals to ozone or chlorine.'4 15 One previous observation has drawn attention to persistent hyperreactivity in subjects exposed acutely to unusually high levels of an irritating aerosol in whom symptoms developed within a few hours and continued for periods of four years or more and in whom bronchial wall biopsy showed inflammation.6 Consistent with this hypothesis is the fact that in two of the three subjects with hyperreactivity who underwent serial testing in this study, recovery to normal levels of reactivity has been observed after seven and 12 months. Verification ofthis possibility would require a longitudinal study with measurements of bronchial reactivity starting before hiring.
Inhalation of substantial quantities of hydrochloric or other soluble gas results in acute inflammation of airways at all levels which may be fatal. 16 Ozone is also an irritant that is known to cause reversible airway narrowing in concentrations of 04-0 5 ppm,'4 although adaptation to these effects has been recorded. 5 In appropriate (lower) concentrations both SO2 and ozone may cause bronchial hyperreactivity without interval airflow obstruction." 18 The levels of exposure to acid fumes experienced by the workers in this study were not documented. By the time they came to medical attention the volume of work in the laboratory had declined considerably, improvements had been made to the extraction of vapours from the fume cupboards, and alterations had been made to the air conditioning system of the laboratory. Further observations in this and similar laboratories will be required to answer scientific and practical questions concerning safe levels of exposure to acid vapours and whether non-specific bronchial reactivity is a determinant of symptoms or consequence of exposure. 
